Pharmacogenetics and the future of medical practice
- 25 March 2003
- journal article
- review article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 81 (3) , 141-153
- https://doi.org/10.1007/s00109-002-0416-5
Abstract
Pharmacogenetics is today widely proclaimed to be about to revolutionize the face of medicine. In a more realistic assessment, the implementation of molecular genetics and biology will continue to provide us, as it has done already, with better ways to diagnose and treat illnesses, but it will do so at a stepwise and evolutionary pace, based on an improved understanding of the nature of disease, allowing more specific treatments, better risk prediction, and the implementation of preventive strategies. As such, future progress in biomedicine will travel the same well-trodden paths of improved differential diagnosis and risk prediction along which it has advanced in the past decades and centuries. Thus, while meaningful biomedical research today by and large depends on the use of the newly developed tools of genetics and genomics and the insights that we gain through them, it is unlikely fundamentally to change the direction of medical progress.Keywords
This publication has 23 references indexed in Scilit:
- Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating AgentsNew England Journal of Medicine, 2000
- Genetic Factors in Aminoglycoside ToxicityAnnals of the New York Academy of Sciences, 1999
- Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression.Journal of Clinical Investigation, 1998
- β2‐adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult populationClinical and Experimental Allergy, 1998
- Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.Journal of Clinical Investigation, 1997
- Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.Journal of Clinical Investigation, 1997
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- Proposed molecular and cellular mechanism for aminoglycoside ototoxicityAntimicrobial Agents and Chemotherapy, 1994
- Amino-Terminal Polymorphisms of the Human .beta.2-Adrenergic Receptor Impart Distinct Agonist-Promoted Regulatory PropertiesBiochemistry, 1994